TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
RNTX

Rein Therapeutics Inc

Healthcare · Biotechnology

0.67$ -7.8% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Rein Therapeutics Inc (RNTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.6% of the shares are freely tradable; institutional investors hold 24.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 24.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 5.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 76.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 86Mio.

Largest Shareholders

Institutions

Institutions RNTX
Name Stake (%) Shares Change (%) Date
Voss Capital LLC 6.10 5,261,921 +19.9 06/30/2026
Cable Car Capital LLC 6.02 5,195,000 +1,136.9 06/30/2026
ADAR1 Capital Management LLC 5.22 4,500,000 +0.0 06/30/2026
Vanguard Capital Management, LLC 3.92 3,377,910 +238.3 06/30/2026
BIOS CAPITAL MANAGEMENT, LP 3.46 2,982,375 +50.4 06/30/2026
Ikarian Capital, LLC 3.42 2,950,000 +0.0 06/30/2026
Great Point Partners LLC 2.98 2,575,000 +0.0 06/30/2026
Citadel Advisors Llc 2.83 2,438,711 +0.0 06/30/2026
Velan Capital Investment Management LP 1.97 1,700,000 +0.0 06/30/2026

Funds

Funds RNTX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.92 2,522,901 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?